Prescription Required
Formulation: Capsule
(Brand Option)
Select the prescribed dosage
Select the quantity to see the price.
Prescription Required
Formulation: Capsule
(Generic Alternative)
Select the prescribed dosage
Select the quantity to see the price.
* This price includes a dispensing fee, medical review fee, and packing fee.
Shipped and delivered directly to your doorstep
Mavik (trandolapril) is a prescription medication used to treat high blood pressure (hypertension) and certain heart conditions following a heart attack.
It contains trandolapril, an active ingredient that belongs to a class of medications called angiotensin-converting enzyme (ACE) inhibitors.
ACE inhibitors work by relaxing and widening blood vessels, allowing blood to flow more easily throughout the body.
By lowering blood pressure and reducing strain on the heart, Mavik helps improve cardiovascular function and reduce the risk of certain serious complications.
Mavik is primarily prescribed for high blood pressure and for clinically stable patients who have developed reduced heart pumping function or heart failure following a heart attack.Â
Mavik is used to treat hypertension, a condition in which blood pressure remains consistently higher than normal.
Blood pressure is the force of circulating blood pushing against the walls of the arteries.
When this pressure remains elevated over time, the heart must work harder to pump blood throughout the body.
Uncontrolled high blood pressure can gradually damage blood vessels and important organs, including the heart, brain, kidneys, and eyes.
It also increases the risk of serious cardiovascular complications, such as heart attack, stroke, and heart failure.
Hypertension often does not cause noticeable symptoms, which is why regular blood pressure monitoring is important.
How Mavik Helps Lower Blood Pressure
Mavik reduces blood pressure by blocking the action of angiotensin-converting enzyme (ACE).
This enzyme helps produce angiotensin II, a hormone that causes blood vessels to narrow.
When blood vessels narrow, blood pressure increases because the heart must pump blood through a smaller space.
Trandolapril reduces the production of angiotensin II, allowing blood vessels to relax and widen.
This helps blood flow more easily and decreases pressure inside the arteries.
Mavik may be prescribed alone or with other blood pressure medications, depending on your medical condition and treatment needs.
Taking Mavik regularly helps control high blood pressure and may reduce the risk of long-term cardiovascular complications.
Mavik is also used in certain patients who have recently experienced a heart attack, medically known as a myocardial infarction.
A heart attack occurs when blood flow to part of the heart muscle becomes blocked, depriving the affected tissue of oxygen.
Without enough oxygen, heart muscle cells may become damaged or die.
After a heart attack, the heart may not pump blood as effectively as it did before.
This can place additional strain on the remaining healthy heart muscle.
Mavik may be prescribed to clinically stable patients who have reduced left ventricular function, with or without symptoms of heart failure.
How Mavik Helps After a Heart Attack
Mavik helps reduce strain on the heart by relaxing blood vessels and lowering the resistance against which the heart must pump.
This makes it easier for the heart to circulate blood throughout the body.
Trandolapril also reduces the effects of angiotensin II, a hormone involved in blood vessel constriction and changes in heart structure.
After a heart attack, the heart may undergo a process called cardiac remodeling.
Cardiac remodeling refers to changes in the size, shape, and function of the heart as it responds to injury.
Excessive remodeling may weaken the heart and contribute to heart failure.
By reducing the activity of the renin-angiotensin system, Mavik helps limit harmful changes in heart structure and function.
Clinical studies have shown that trandolapril can improve survival and reduce heart failure-related hospitalizations in selected patients with left ventricular dysfunction following a heart attack.Â
Mavik is indicated for certain patients who develop heart failure or reduced pumping function after a myocardial infarction.
Heart failure occurs when the heart cannot pump blood effectively enough to meet the body’s needs.
This does not mean the heart has stopped working. Instead, it means the heart’s pumping ability has become reduced or its function has otherwise been impaired.
When the heart cannot circulate blood effectively, fluid may accumulate in the lungs, legs, or other tissues.
Common symptoms of heart failure include shortness of breath, fatigue, swelling in the feet or ankles, and difficulty performing physical activities.
Some people may also experience rapid weight gain due to fluid retention.
Mavik reduces the workload on the heart by relaxing blood vessels and lowering blood pressure.
This allows the heart to pump blood with less resistance.
Trandolapril also reduces the production of aldosterone, a hormone that encourages the body to retain sodium and water.
Lower aldosterone activity may help reduce excess fluid retention and ease some of the strain on the cardiovascular system.
In patients with impaired left ventricular function after a heart attack, these effects may help reduce the risk of worsening heart failure.
Mavik may also help decrease the likelihood of hospitalization for heart failure.
Important: Mavik’s specific approved heart failure indication concerns clinically stable patients with heart failure or left ventricular dysfunction following a heart attack. It should not be described as an approved treatment for every form of heart failure.
Your healthcare provider will determine whether Mavik is appropriate based on your heart function, blood pressure, kidney function, and medical history.Â
Mavik belongs to a class of medications called angiotensin-converting enzyme (ACE) inhibitors.
It works by affecting the renin-angiotensin-aldosterone system (RAAS), which helps regulate blood pressure, fluid balance, and blood vessel function.
This system plays an important role in maintaining normal circulation.
However, excessive activity can contribute to high blood pressure and increased strain on the heart.
Blocks the Angiotensin-Converting Enzyme
After trandolapril is absorbed into the body, it is converted into its active form, called trandolaprilat.
Trandolaprilat inhibits the angiotensin-converting enzyme.
This reduces the production of angiotensin II, a hormone that normally causes blood vessels to narrow.
By lowering angiotensin II levels, Mavik helps blood vessels remain more relaxed.
Relaxes and Widens Blood Vessels
When blood vessels relax and widen, blood can flow more easily.
This reduces resistance within the arteries and helps lower blood pressure.
Lower blood pressure decreases the amount of work the heart must perform to circulate blood throughout the body.
This can be especially beneficial in patients with hypertension or reduced heart function following a heart attack.
Reduces Sodium and Water Retention
Angiotensin II also stimulates the release of aldosterone.
Aldosterone is a hormone that encourages the kidneys to retain sodium and water.
Excessive sodium and water retention can contribute to increased blood volume and higher blood pressure.
By reducing angiotensin II activity, Mavik also decreases aldosterone stimulation.
This may help reduce sodium and water retention.
However, reducing aldosterone can also increase potassium levels in the blood.
Your healthcare provider may recommend regular blood tests to monitor potassium and kidney function.
Reduces Strain on the Heart
Mavik helps the heart pump blood against less resistance.
This reduces the workload on the heart and may help protect the heart from harmful structural changes following a heart attack.
In selected patients with reduced left ventricular function after myocardial infarction, these effects can improve long-term cardiovascular outcomes.
Mavik begins lowering blood pressure after the medication is absorbed and converted into its active form.
Some blood pressure reduction may occur within the first few hours after taking a dose.
However, the full blood pressure-lowering effect may take several weeks of regular treatment.
Your healthcare provider may adjust your dosage based on your blood pressure readings and response.
Because high blood pressure often causes no noticeable symptoms, you may not feel different even when Mavik is working.
If you are taking Mavik after a heart attack, the benefits of treatment may develop over time.
Your healthcare provider may monitor your heart function, blood pressure, kidney function, and potassium levels throughout treatment.
Continue taking Mavik exactly as prescribed, even if you feel well.
Mavik may cause side effects such as dizziness, headache, low blood pressure, and a persistent dry cough.
More serious potential complications include increased potassium levels, kidney problems, and angioedema.
Angioedema is a serious reaction that can cause sudden swelling of the face, lips, tongue, or throat.
Seek emergency medical attention if you experience facial or throat swelling or difficulty breathing.
Mavik must not be used during pregnancy because ACE inhibitors can cause serious harm or death to a developing baby.
Tell your healthcare provider if you have kidney disease, liver disease, a history of angioedema, or take potassium supplements or other blood pressure medications.
Regular monitoring may be necessary to ensure treatment remains safe and effective.
Mavik is a prescription medication used to treat high blood pressure (hypertension) and certain heart conditions following a heart attack.
It belongs to a class of medications called angiotensin-converting enzyme (ACE) inhibitors. These medications help relax and widen blood vessels, allowing blood to flow more easily and reducing the workload on the heart.
In Canada, Mavik comes in capsule form and is taken by mouth, usually once daily, with or without food. Some patients may be prescribed two daily doses if their blood pressure is not adequately controlled with once-daily treatment.
Your healthcare provider will determine the appropriate dosage based on your medical condition, blood pressure readings, kidney function, liver function, and response to treatment.
Take Mavik exactly as prescribed. Do not increase your dose, change your dosing schedule, or stop taking the medication without medical advice.
Mavik capsules should be taken by mouth with water.
Follow these instructions to help ensure safe and effective treatment:
If you experience dizziness after taking Mavik, avoid driving or operating machinery until you know how the medication affects you.
The appropriate dosage of Mavik depends on the condition being treated.
Your healthcare provider may start with a low dose and gradually increase it to reduce the risk of side effects.
This approach is particularly important for patients who take diuretics, have reduced kidney function, or may be more sensitive to blood pressure changes.
Dosage for High Blood Pressure
For adults with hypertension who are not taking a diuretic, a common starting dose is 1 mg once daily, although some patients may require a different initial dose.
Your healthcare provider will monitor your blood pressure and adjust the dosage as necessary.
The usual maintenance dose is often 2 mg to 4 mg daily.
Most patients take Mavik once daily, but some may be instructed to divide their total daily dose into two doses.
Dosage adjustments should generally be made gradually, allowing enough time to assess the medication’s effect.
Dosage Following a Heart Attack
Mavik may be prescribed to clinically stable patients who have reduced left ventricular function or heart failure following a heart attack.
The left ventricle is the main pumping chamber of the heart. Damage following a heart attack may reduce its ability to pump blood effectively.
Treatment is generally started at a low dose and gradually increased as tolerated.
A commonly recommended starting dose is 1 mg once daily, with a target dose of 4 mg daily in patients who can tolerate it.
However, your healthcare provider may recommend a lower starting dose depending on your blood pressure, kidney function, and overall condition.
Never use another patient’s dosage as a guide for your own treatment. The appropriate dose must be determined individually.Â
Starting Mavik at a low dose helps reduce the risk of side effects, particularly excessive lowering of blood pressure.
Mavik relaxes blood vessels, making it easier for blood to circulate.
In some patients, this effect may cause blood pressure to fall too quickly, especially when treatment first begins.
Possible symptoms include dizziness, lightheadedness, weakness, or fainting.
The risk may be greater in people who are dehydrated, taking diuretics, or following a salt-restricted diet.
Your healthcare provider may gradually increase your dosage after evaluating your blood pressure and treatment response.
This process is called dose titration.
Do not increase your dose because your blood pressure has not improved immediately. Your healthcare provider will determine when a dosage adjustment is appropriate.
Yes. Mavik can generally be taken with or without food.
You may take the capsule before, during, or after a meal, depending on what is most convenient for you.
Taking the medication at approximately the same time each day can help you maintain a consistent routine.
If you experience mild stomach discomfort, taking Mavik with food may help.
Swallow your prescribed dose with water.
If your healthcare provider has recommended a specific dosing time, follow those instructions.
Taking Mavik consistently helps maintain regular blood pressure control.
Mavik works by reducing the production of angiotensin II, a hormone that causes blood vessels to narrow.
When blood vessels relax, blood can flow more easily and blood pressure decreases.
Taking the medication regularly helps maintain its intended effect throughout the treatment period.
Missing doses may reduce blood pressure control, while taking extra doses may cause blood pressure to fall too low.
Consider setting a daily reminder or taking Mavik as part of your morning routine.
If you are prescribed two daily doses, follow the timing instructions provided by your healthcare provider.
Mavik begins lowering blood pressure within the first few hours after taking a dose.
However, its full effect develops with regular treatment.
For many patients with hypertension, the maximum blood pressure reduction at a particular dose is reached within approximately one week.
Your healthcare provider may continue monitoring your blood pressure over several weeks to determine whether the dosage needs adjustment.
Because high blood pressure often causes no noticeable symptoms, you may not feel different even when Mavik is working.
Regular blood pressure measurements are the best way to determine whether Mavik is effectively controlling your hypertension.Â
Mavik may be prescribed after a heart attack to help protect the heart and reduce the risk of certain complications.
Its effects on blood vessel relaxation and blood pressure begin relatively quickly.
However, the longer-term benefits of treatment, such as reducing harmful changes in heart structure and lowering the risk of heart failure-related hospitalization, develop over time.
These benefits cannot always be measured by how you feel.
Your healthcare provider may use blood pressure readings, blood tests, physical examinations, and heart imaging to monitor your recovery.
Some patients may notice improvements in symptoms over several weeks, while others may need longer-term treatment to obtain protective cardiovascular benefits.
Continue taking Mavik for as long as your healthcare provider recommends, even if you do not notice immediate changes in your symptoms.
If you forget to take Mavik, take the missed dose as soon as you remember unless it is almost time for your next scheduled dose.
If your next dose is approaching, skip the missed dose and continue with your regular dosing schedule.
Do not take two doses at once to make up for a missed dose.
Taking extra medication may cause your blood pressure to drop too low, leading to dizziness, weakness, or fainting.
If you frequently forget doses, consider using a medication organizer or setting reminders.
Contact your healthcare provider or pharmacist if you are unsure how to manage a missed dose.
Do not stop taking Mavik simply because your blood pressure readings have improved.
High blood pressure is often a long-term condition that requires ongoing treatment.
Mavik helps control blood pressure while you are taking it, but it does not permanently cure hypertension.
If you stop taking the medication, your blood pressure may rise again.
This can increase the risk of serious complications, including heart attack, stroke, and kidney damage.
If you are taking Mavik following a heart attack, stopping treatment may also remove its ongoing protective effects on the heart.
Your healthcare provider will determine whether treatment should continue, be adjusted, or be replaced.
Do not discontinue Mavik without consulting your healthcare provider.
Patients with kidney or liver problems may require a lower starting dose of Mavik.
The kidneys help remove trandolapril’s active metabolite from the body, while the liver plays an important role in converting the medication into its active form.
Significant impairment of either organ may affect medication processing and increase the risk of side effects.
For example, some prescribing information recommends an initial dose of 0.5 mg daily for patients with severe kidney impairment or hepatic cirrhosis.
Your healthcare provider will determine whether dosage adjustments are necessary based on laboratory results and medical history.
Mavik may also increase potassium levels in the blood.
For this reason, your healthcare provider may recommend blood tests to monitor kidney function and electrolytes during treatment.
Mavik may cause dizziness, lightheadedness, low blood pressure, or a persistent dry cough.
Tell your healthcare provider if you take diuretics, potassium supplements, potassium-containing salt substitutes, or other medications that affect blood pressure or kidney function.
Mavik can also cause a serious reaction called angioedema, which involves sudden swelling of the face, lips, tongue, or throat.
Seek emergency medical attention if you develop facial or throat swelling or difficulty breathing.
Mavik must not be used during pregnancy because ACE inhibitors can cause serious harm to a developing baby. If you become pregnant, stop taking Mavik and contact your healthcare provider immediately for an alternative treatment.
Contact your healthcare provider if your blood pressure readings remain consistently above your recommended target or if you experience persistent dizziness, weakness, or other concerning side effects.
Seek medical advice if you develop a persistent dry cough, unusual changes in urination, or symptoms suggesting high potassium levels, such as muscle weakness or an irregular heartbeat.
Seek emergency medical attention for severe chest pain, difficulty breathing, fainting with serious symptoms, or swelling of the tongue or throat.
Mavik (Trandolapril) is available in the following forms and strength:
Mavik is a prescription medication used to treat high blood pressure (hypertension) and certain heart conditions following a heart attack.
It belongs to a class of medications called angiotensin-converting enzyme (ACE) inhibitors. These medications help relax blood vessels, lower blood pressure, and reduce the workload on the heart.
Although Mavik can help protect your cardiovascular health, it may cause serious side effects in some patients.
Before starting treatment, tell your healthcare provider about your medical history, allergies, and all medications and supplements you take.
Do not take Mavik if you have a known allergy to trandolapril or any other ingredient in the medication.
Tell your healthcare provider if you have previously experienced an allergic reaction to another ACE inhibitor, such as lisinopril, ramipril, enalapril, or benazepril.
One particularly serious reaction associated with ACE inhibitors is angioedema.
Angioedema causes sudden swelling beneath the skin, particularly around the face, lips, tongue, or throat.
The swelling can obstruct the airway and make breathing difficult.
Mavik must not be used by patients with a history of ACE inhibitor-related angioedema or hereditary or idiopathic angioedema.
Seek emergency medical attention if you experience swelling of the face, tongue, or throat, especially if you have difficulty breathing or swallowing.
Tell your healthcare provider if you have kidney disease or reduced kidney function before taking Mavik.
The kidneys help filter waste products from the blood and regulate fluid and electrolyte balance.
Trandolapril affects the renin-angiotensin system, which plays an important role in maintaining blood pressure and kidney function.
In some patients, particularly those with existing kidney problems, Mavik may cause kidney function to worsen.
The risk may be greater in people with renal artery stenosis, severe dehydration, or certain types of heart failure.
Renal artery stenosis occurs when the arteries supplying blood to the kidneys become narrowed.
Your healthcare provider may recommend blood tests to monitor creatinine, kidney function, and potassium levels before and during treatment.
Contact your healthcare provider if you notice significantly reduced urination, unusual swelling, persistent weakness, or other symptoms suggesting kidney problems.
Tell your healthcare provider if you have liver disease or a history of liver problems.
Trandolapril is converted in the body into its active form, called trandolaprilat.
The liver plays a role in this process.
Patients with significant liver impairment may process the medication differently, potentially increasing the risk of side effects.
Your healthcare provider may recommend a lower starting dose or additional monitoring.
Rarely, ACE inhibitors have been associated with serious liver complications.
Possible symptoms include yellowing of the skin or eyes, dark urine, persistent nausea, unusual fatigue, and abdominal discomfort.
Yellowing of the skin or eyes is called jaundice and may indicate liver injury.
Stop taking Mavik and seek prompt medical evaluation if you develop jaundice or other symptoms suggesting serious liver problems.
Mavik is used to treat certain cardiovascular conditions, but patients with significant heart disease may require closer monitoring.
Mavik lowers blood pressure by relaxing and widening blood vessels.
In some patients, this effect may cause blood pressure to fall too low.
This condition is called hypotension.
Possible symptoms include dizziness, weakness, blurred vision, lightheadedness, and fainting.
People with heart failure, dehydration, or those taking diuretics may be more likely to experience excessive blood pressure reduction.
Your healthcare provider may recommend starting with a lower dose and increasing it gradually.
Seek urgent medical attention if you experience fainting, severe weakness, or symptoms suggesting dangerously low blood pressure.
Mavik must not be used during pregnancy because it can cause serious harm or death to a developing baby.
Trandolapril affects the renin-angiotensin system, which is important for regulating blood pressure and supporting fetal kidney development.
Exposure to ACE inhibitors during pregnancy, particularly during the second and third trimesters, can interfere with normal fetal kidney function.
Possible complications include reduced amniotic fluid, kidney damage, abnormal lung development, and fetal or newborn death.
Amniotic fluid is the liquid that surrounds and protects a developing baby during pregnancy.
Tell your healthcare provider if you are pregnant, planning to become pregnant, or think you may be pregnant.
If pregnancy occurs while taking Mavik, stop taking it and contact your healthcare provider immediately.
Your healthcare provider will recommend an alternative blood pressure treatment that is appropriate during pregnancy.
Do not leave high blood pressure untreated during pregnancy, as uncontrolled hypertension can also cause serious complications.
Mavik may interact with certain prescription medications, over-the-counter drugs, and supplements.
Some interactions can increase the risk of low blood pressure, high potassium levels, or kidney problems.
Important medications and products include:
Certain combinations involving medications that affect the renin-angiotensin system require special precautions.
For example, Mavik should not be taken with aliskiren in patients with diabetes.
Mavik must also not be used together with sacubitril/valsartan because of the increased risk of angioedema. A separation period of at least 36 hours is required when switching between these medications.
Tell your healthcare provider about all medications, vitamins, herbal supplements, and salt substitutes you use before starting Mavik.
Mavik may increase potassium levels in the blood, a condition called hyperkalemia.
Potassium is an important mineral that helps regulate muscle contractions, nerve signaling, and normal heart rhythm.
Trandolapril reduces the production of aldosterone, a hormone that helps the kidneys regulate sodium and potassium.
When aldosterone activity decreases, the body may retain more potassium.
The risk is higher in people with kidney disease, diabetes, or those taking potassium supplements or potassium-sparing diuretics.
Mild hyperkalemia may not cause noticeable symptoms.
However, severe cases can cause muscle weakness, nausea, tingling sensations, or irregular heartbeats.
Your healthcare provider may recommend regular blood tests to monitor potassium levels.
Do not take potassium supplements or use potassium-containing salt substitutes unless your healthcare provider recommends them.Â
Older adults may be more sensitive to certain side effects of Mavik, especially dizziness, low blood pressure, and changes in kidney function.
As people age, kidney function may gradually decline, and the body may become less efficient at maintaining normal fluid balance.
Older adults are also more likely to take several medications, which can increase the possibility of drug interactions.
Your healthcare provider may recommend a lower starting dose or closer monitoring, depending on your overall health and kidney function.
Stand up slowly after sitting or lying down to reduce the risk of dizziness and falls.
Age alone does not automatically mean that Mavik is unsuitable. Treatment should be based on your medical condition and individual response.
Mavik may cause dizziness or lightheadedness, particularly when treatment begins or your dosage is increased.
These symptoms occur because the medication lowers blood pressure by relaxing blood vessels.
Some people may experience a sudden drop in blood pressure when standing up.
This is called orthostatic hypotension.
Symptoms may include dizziness, blurred vision, weakness, or feeling as though you are about to faint.
The risk may increase if you are dehydrated, sweating excessively, or experiencing vomiting or diarrhea.
Avoid driving, operating machinery, or performing potentially dangerous activities until you know how Mavik affects you.
If you feel dizzy, sit or lie down until the symptoms improve.
Contact your healthcare provider if dizziness becomes persistent or you experience fainting.Â
Mavik may cause a persistent dry cough in some patients.
This is a known side effect of ACE inhibitors.
The cough is usually dry, meaning it does not produce mucus, and may feel like a persistent tickling sensation in the throat.
It occurs partly because ACE inhibitors reduce the breakdown of bradykinin, a naturally occurring substance involved in blood vessel function.
In some people, increased bradykinin activity may contribute to coughing.
The cough may develop shortly after treatment begins or after several weeks or months.
Although usually not dangerous, it may interfere with sleep or everyday activities.
Tell your healthcare provider if you develop a persistent cough while taking Mavik.
Your provider may evaluate whether Mavik is responsible or whether another condition is causing the symptom.
If necessary, a different blood pressure medication may be recommended.
Do not stop taking Mavik on your own because of a cough. Your healthcare provider can help determine the safest treatment adjustment.Â
Alcohol may increase certain side effects of Mavik, particularly dizziness, lightheadedness, and low blood pressure.
Mavik relaxes blood vessels to reduce blood pressure.
Alcohol can also affect blood vessel function and temporarily lower blood pressure.
When combined, these effects may increase the likelihood of feeling faint or unsteady.
The risk may be greater when you first start treatment, after a dosage increase, or if you are dehydrated.
Avoid alcohol until you know how Mavik affects you.
If you choose to drink alcohol, discuss an appropriate amount with your healthcare provider.
Avoid driving or operating machinery if you experience dizziness or reduced alertness.
Mavik may increase potassium levels in the blood.
For this reason, certain supplements and salt substitutes may require caution.
Potassium-containing salt substitutes are particularly important because they may provide a large amount of potassium.
Taking potassium supplements while using Mavik can also increase the risk of hyperkalemia.
However, most patients do not need to avoid all potassium-rich foods.
Foods such as bananas, oranges, potatoes, tomatoes, and leafy greens can be part of a balanced diet.
Whether dietary potassium restrictions are necessary depends on your kidney function, blood potassium levels, and other medications.
Do not eliminate healthy foods from your diet or begin potassium supplements without discussing your individual needs with your healthcare provider.
Contact your healthcare provider if you experience persistent dizziness, unusual weakness, a dry cough that does not improve, or changes in urination.
You should also report symptoms that may indicate low blood pressure, kidney problems, or high potassium levels.
Seek urgent medical attention if you experience fainting, severe weakness, or a new irregular heartbeat accompanied by concerning symptoms.
Seek emergency medical attention if you develop swelling of the face, lips, tongue, or throat, difficulty breathing, severe chest pain, or symptoms of a serious allergic reaction.
Alcohol may increase certain side effects of Mavik, particularly dizziness, lightheadedness, and low blood pressure. Mavik belongs to a class of medications called angiotensin-converting enzyme (ACE) inhibitors. It works by relaxing and widening blood vessels, allowing blood to flow more easily and lowering blood pressure. Alcohol can also affect blood vessels and may temporarily lower blood pressure. When alcohol and Mavik are combined, their blood pressure-lowering effects may increase the risk of hypotension, a condition in which blood pressure becomes too low. Possible symptoms include dizziness, weakness, blurred vision, lightheadedness, or fainting. These effects may be more noticeable when you first start taking Mavik, after a dosage increase, or if you are dehydrated. Avoid alcohol until you know how Mavik affects you. If you choose to drink alcohol, discuss an appropriate amount with your healthcare provider. Do not drive or operate machinery if you experience dizziness or reduced alertness.
No. Mavik must not be taken during pregnancy because it can cause serious harm or death to a developing baby. Trandolapril affects the renin-angiotensin system, which plays an important role in regulating blood pressure and supporting fetal kidney development. Taking ACE inhibitors during pregnancy, particularly during the second and third trimesters, can interfere with normal fetal kidney function. Possible complications include kidney damage, reduced amniotic fluid, abnormal lung development, and fetal or newborn death. Amniotic fluid is the liquid that surrounds and protects a developing baby during pregnancy. If you become pregnant while taking Mavik, stop taking the medication and contact your healthcare provider immediately. Your healthcare provider will recommend another blood pressure medication that is appropriate during pregnancy. If you are planning to become pregnant, discuss alternative treatment options with your healthcare provider before conception. High blood pressure also requires careful management during pregnancy, so it is important not to leave the condition untreated.
Yes. Mavik contains the active ingredient trandolapril, which is available as a generic medication in certain markets. Generic trandolapril belongs to the same class of medications as brand-name Mavik and works by inhibiting the angiotensin-converting enzyme. This helps relax blood vessels, lower blood pressure, and reduce the workload on the heart. Generic medications must meet applicable regulatory standards for quality, strength, and effectiveness. They are often less expensive than brand-name medications, although the actual price depends on the pharmacy, location, insurance coverage, and availability. Trandolapril may be supplied in different strengths, depending on the manufacturer and country. Ask your pharmacist whether generic trandolapril is available and appropriate for your prescription. Do not change the strength, formulation, or prescribed dosage without consulting your healthcare provider or pharmacist.
If you forget to take Mavik, take the missed dose as soon as you remember, unless it is almost time for your next scheduled dose. If your next dose is approaching, skip the missed dose and continue with your regular dosing schedule. Do not take two doses at the same time to make up for a missed dose. Taking more trandolapril than prescribed may cause your blood pressure to drop too low. This can result in dizziness, lightheadedness, weakness, blurred vision, or fainting. Mavik helps control blood pressure when taken regularly. Missing doses may reduce its effectiveness and allow your blood pressure to rise. To help you remember your medication, take Mavik at approximately the same time each day. You may also consider setting a phone reminder or using a medication organizer. If you frequently miss doses or are unsure when to take your next capsule, contact your healthcare provider or pharmacist for advice.Â
Mavik begins lowering blood pressure within a few hours after taking a dose. It works by blocking the angiotensin-converting enzyme (ACE), which is involved in producing angiotensin II, a hormone that causes blood vessels to narrow. By reducing angiotensin II activity, Mavik allows blood vessels to relax and widen, making it easier for blood to circulate. Some patients may experience a noticeable reduction in blood pressure within approximately two hours, with the greatest effect of an individual dose occurring around eight hours. However, it may take approximately one week or longer for the full blood pressure-lowering effect of a particular dose to develop. Your healthcare provider may monitor your blood pressure over several weeks to determine whether the medication is working effectively. If you are taking Mavik after a heart attack, its protective benefits may develop over a longer period. These benefits may include reducing strain on the heart and lowering the risk of certain cardiovascular complications. Because high blood pressure often causes no noticeable symptoms, you may not feel different even when Mavik is working. Continue taking Mavik exactly as prescribed, even if you feel well or your blood pressure readings improve. Contact your healthcare provider if your blood pressure remains consistently above your recommended target or if your condition becomes worse.Â
Mavik should be stored properly to maintain its quality and effectiveness. According to the Canadian manufacturer’s storage instructions, Mavik capsules should be stored at room temperature between 15°C and 25°C (59°F and 77°F). Keep the medication in its original container and protect it from excessive heat, light, and moisture. Avoid storing Mavik in bathrooms, where humidity and temperature changes may affect medication quality. Keep the container tightly closed when not in use. Store Mavik in a secure location away from children and pets. Do not use the medication after its expiration date. If your capsules appear damaged, discoloured, or unusual in appearance, ask your pharmacist whether they are safe to use. Do not flush unused medication down the toilet or throw it directly into household garbage unless local disposal instructions specifically permit it. Instead, return expired or unused medication to a pharmacy that offers medication disposal services. Proper storage helps maintain the medication’s effectiveness and reduces the risk of accidental exposure.
| Generic name: | Trandolapril |
|---|---|
| Formulation: | Capsule |
| Strength(s): | 0.5mg, 1mg, 2mg, 4mg |
| Quantities Available: | 84, 100 |
Our online Canadian Pharmacy is known for high standards of quality, safety, and efficiency when it comes to medications.
Our pharmacy offers lower prices on prescription drugs compared to traditional pharmacies.
When ordering Mavik (trandolapril) from a Canadian pharmacy, you can typically purchase up to a 90-day supply at one time, which is common for prescription medications to ensure adequate management of chronic conditions without frequent refills.
Here’s what you need to know:
Dosage and Quantity: Mavik is commonly prescribed in dosages of 0.5 mg, 1 mg, or 2 mg, taken once daily. For a 90-day supply, this means you would order 90 capsules (90 days x 1 capsule per day) of the prescribed dosage.
Yes, we sell trandolapril on our website. You can enjoy low prices when you order through us. To purchase trandolapril, you will need a valid prescription from your healthcare provider. We require this prescription to dispense the medication safely and appropriately. You can submit your prescription by mailing it to us, faxing it, or uploading it through your online account.
Yes, we ship Mavik (trandolapril) to both the United States and Puerto Rico.
Watch how Online Pharmacies Canada is helping customers save money on their medications.
Online Pharmacies Canada has provided information from third parties intended to increase awareness and does not contain all the information about Mavik (Trandolapril). Talk to your doctor or other qualified medical practitioners for medical attention or advice, or if you have any concerns about Mavik (Trandolapril).
REVIEWS